/Pfizer%20Inc_%20NY%20HQ-by%20JHVEPhoto%20via%20iStock.jpg)
Valued at a market cap of $164.8 billion, Pfizer Inc. (PFE) discovers, manufactures, distributes, and markets medicines and vaccines in various therapeutic areas, including immunology, oncology, cardiology, endocrinology, and neurology, among others, and is renowned for its Pfizer–BioNTech COVID-19 vaccine. The New York-based company is expected to announce its fiscal Q3 earnings results before the market opens on Tuesday, Oct. 29.
Ahead of this event, analysts project the biopharmaceutical company to report a profit of $0.62 per share, up 464.7% from a loss of $0.17 per share in the year-ago quarter. The company has consistently beaten Wall Street's bottom-line estimates in the last four quarters.